BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2007
View Archived Issues
DOV reports positive phase Ib data for its lead TRIP in depression
Read More
Recent patents cover novel agents for neurologic disorders
Read More
Bayer describes new thrombin inhibitors
Read More
Roche and Schering-Plough separately claim novel compounds for obesity and related disordes
Read More
PRLX-93936's antitumor activity profiled by Prolexys
Read More
Recombinant human IL-18 to be tested in NHL
Read More
AnGes submits Naglazyme BLA to Japanese Ministry of Health
Read More
Fosaprepitant tolerability, bioequivalency with oral aprepitant explored
Read More
Genta announces initiation of Genasense named-patient/compassionte program
Read More
Enrollment completed for Pervasis' phase II trial of Vascugel for ESRD
Read More
FoldRx and CFFT enter collaboration agreement for cystic fibrosis research
Read More
Study finds regadenoson safe in subjects with decreased renal function
Read More
Polyphenolic grape extract activity may explain cardiovascular benefits of red wine
Read More
Recruitment completed for pSivida phase IIa study of BrachySil
Read More
Anti-IL-18 antibody ABT-325 profiled at Abbott
Read More
Cardiome Pharma reports second quarter 2007 results
Read More
New PI3K inhibitor described by Merck Serono
Read More
Second quarter 2007 results reported by Biomarin
Read More
Avigen initiates AV-411 clinical development in the U.S.
Read More
Metabolic discontinues ACV-1 clinical trial
Read More
Arpida closes TLT acquisition
Read More
Esprit Pharma acquires Sanctura XR marketing rights
Read More
EMEA accepts Santhera's filing of SNT-MC17 for Friedreich's ataxia
Read More